BFRG · BullFrog AI Holdings, Inc. · Insider Trading

The price reported in Column 4 is a weighted average price. The shares of common stock (the "Shares") of BullFrog AI Holdings, Inc. (the "Issuer") were purchased by the Reporting Person at prices ranging from $0.5169 to $0.65, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 1 to this Form 4.

The price reported in Column 4 is a weighted average price. The shares of common stock (the "Shares") of BullFrog AI Holdings, Inc. (the "Issuer") were purchased by the Reporting Person at prices ranging from $0.52 to $0.5294, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 1 to this Form 4.

The options were issued as a grant under the Plan, based on the market price on the date of the grant.

Represents stock options issued under BullFrog AI Holdings, Inc.'s (the "Company") 2022 Equity Compensation Plan, as amended from time to time (the "Plan"), which vest on June 11, 2027. Lapse of forfeiture restrictions will accelerate upon a change in control of the Company (as defined in the Plan) or a significant financing, which may, or may not, constitute a change in control.

The stock options expire on June 12, 2036.

The options were issued as a grant under the Plan, based on the market price on the date of the grant.

Represents stock options issued under BullFrog AI Holdings, Inc.'s (the "Company") 2022 Equity Compensation Plan, as amended from time to time (the "Plan"), which vest on June 11, 2027. Lapse of forfeiture restrictions will accelerate upon a change in control of the Company (as defined in the Plan) or a significant financing, which may, or may not, constitute a change in control.

The stock options expire on June 12, 2036.

The options were issued as a grant under the Plan, based on the market price on the date of the grant.

Represents stock options issued under BullFrog AI Holdings, Inc.'s (the "Company") 2022 Equity Compensation Plan, as amended from time to time (the "Plan"), which vest on June 11, 2027. Lapse of forfeiture restrictions will accelerate upon a change in control of the Company (as defined in the Plan) or a significant financing, which may, or may not, constitute a change in control.

The stock options expire on June 12, 2036.

The options were issued as a grant under the Plan, based on the market price on the date of the grant.

Represents stock options issued under Bullfrog AI Holdings, Inc.'s (the "Company") 2022 Equity Compensation Plan, as amended from time to time (the "Plan"), vesting on the earlier of September 25, 2026 and the date of the Company's annual meeting for fiscal year 2026. Lapse of forfeiture restrictions will accelerate upon a change in control of the Company (as defined in the Plan) or a significant financing which may, or may not, constitute a change in control.

The stock options expire on September 25, 2035.

The options were issued as a grant under the Plan, based on the market price on the date of the grant.

Represents stock options issued under Bullfrog AI Holdings, Inc.'s (the "Company") 2022 Equity Compensation Plan, as amended from time to time (the "Plan"), vesting on the earlier of September 25, 2026 and the date of the Company's annual meeting for fiscal year 2026. Lapse of forfeiture restrictions will accelerate upon a change in control of the Company (as defined in the Plan) or a significant financing which may, or may not, constitute a change in control.

The stock options expire on September 25, 2035.

The options were issued as a grant under the Plan, based on the market price on the date of the grant.

Represents stock options issued under Bullfrog AI Holdings, Inc.'s (the "Company") 2022 Equity Compensation Plan, as amended from time to time (the "Plan"), vesting on the earlier of September 25, 2026 and the date of the Company's annual meeting for fiscal year 2026. Lapse of forfeiture restrictions will accelerate upon a change in control of the Company (as defined in the Plan) or a significant financing which may, or may not, constitute a change in control.

The stock options expire on September 25, 2035.

Represents 2,813 shares of Common Stock issued as an equity grant under the Plan, fully vested upon grant.

Represents 4,950 shares of Common Stock issued as an equity grant under the Plan, fully vested upon grant.

Represents Restricted Stock Units ("RSUs") issued under the Plan, vesting 50% on September 1, 2026, and the remaining 50% on September 1, 2027. Lapse of forfeiture restrictions will accelerate upon a change in control of the Company (as defined in the Plan) or a significant financing which may, or may not, constitute a change in control. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

Represents Restricted Stock Units ("RSUs") issued under the Company's 2022 Equity Compensation Plan (the "Plan"), vesting 50% on September 1, 2026, and the remaining 50% on September 1, 2027. Lapse of forfeiture restrictions will accelerate upon a change in control of the Company (as defined in the Plan) or a significant financing which may, or may not, constitute a change in control. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

Represents Restricted Stock Units ("RSUs") issued under the Company's 2022 Equity Compensation Plan (the "Plan"), vesting 50% on September 1, 2026, and the remaining 50% on September 1, 2027. Lapse of forfeiture restrictions will accelerate upon a change in control of the Company (as defined in the Plan) or a significant financing which may, or may not, constitute a change in control. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

Represents 75,000 shares of Common Stock issued as an equity grant under the Company's 2022 Equity Compensation Plan (the "Plan"), fully vested upon grant.

Represents Restricted Stock Units ("RSUs") issued under the Company's 2022 Equity Compensation Plan (the "Plan"), vesting 50% on September 1, 2026, and the remaining 50% on September 1, 2027. Lapse of forfeiture restrictions will accelerate upon a change in control of the Company (as defined in the Plan) or a significant financing which may, or may not, constitute a change in control. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

Represents Restricted Stock Units ("RSUs") issued under the Company's 2022 Equity Compensation Plan (the "Plan"), vesting 50% on September 1, 2026, and the remaining 50% on September 1, 2027. Lapse of forfeiture restrictions will accelerate upon a change in control of the Company (as defined in the Plan) or a significant financing which may, or may not, constitute a change in control. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

Represents 2,813 shares of Common Stock issued as an equity grant under the Plan, fully vested upon grant.

Represents 2,813 shares of Common Stock issued as an equity grant under the Plan, fully vested upon grant.

On July 7, 2025, Mr. Singh sold an aggregate of 29,002 shares of the Issuer's common stock pursuant to a Rule 10b5-1 sales plan at an average price of $1.5042. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person will provide full information regarding the number of shares purchased at each separate price.

On July 3, 2025, Mr. Singh sold an aggregate of 6,039 shares of the Issuer's common stock pursuant to a Rule 10b5-1 sales plan at an average price of $1.6104. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person will provide full information regarding the number of shares purchased at each separate price.

On July 2, 2025, Mr. Singh sold an aggregate of 7,554 shares of the Issuer's common stock pursuant to a Rule 10b5-1 sales plan at an average price of $1.5695. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person will provide full information regarding the number of shares purchased at each separate price.

On July 1, 2025, Mr. Singh sold an aggregate of 7,405 shares of the Issuer's common stock pursuant to a Rule 10b5-1 sales plan at an average price of $1.53. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person will provide full information regarding the number of shares purchased at each separate price.

On April 4, 2025, Mr. Singh sold an aggregate of 5,895 shares of the Issuer's common stock pursuant to a Rule 10b5-1 sales plan at an average price of $1.3039. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person will provide full information regarding the number of shares purchased at each separate price.

On April 3, 2025, Mr. Singh sold an aggregate of 27,958 shares of the Issuer's common stock pursuant to a Rule 10b5-1 sales plan at an average price of $1.4369. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person will provide full information regarding the number of shares purchased at each separate price.

On April 2, 2025, Mr. Singh sold an aggregate of 8,902 shares of the Issuer's common stock pursuant to a Rule 10b5-1 sales plan at an average price of $1.6401. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person will provide full information regarding the number of shares purchased at each separate price.

On April 1, 2025, Mr. Singh sold an aggregate of 7,245 shares of the Issuer's common stock pursuant to a Rule 10b5-1 sales plan at an average price of $1.6059. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person will provide full information regarding the number of shares purchased at each separate price.

The options vest in equal amounts as follows: (i) 25,000 options were immediately vested on the date of grant; (ii) 25,000 options vest on the one year anniversary of the date of grant; and (iii) 25,000 options vest on the two year anniversary of the date of grant.

The options were granted pursuant to the Company's 2022 Equity Incentive Plan.

The options expire on January 28, 2035.

On July 5, 2024, Mr. Singh sold 5,695 shares of Issuer's common stock at an average price of $2.5680 per share. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person shall provide full information regarding the number of shares purchased at each separate price.

The options vest on September 26, 2025.

The options were issued as a grant under the Company's equity incentive plan based on the market price on the date of the grant.

The options expire on September 26, 2034.

The options vest on September 26, 2025.

The options were issued as a grant under the Company's equity incentive plan based on the market price on the date of the grant.

The options expire on September 26, 2034.

The options vest on September 26, 2025.

The options were issued as a grant under the Company's equity incentive plan based on the market price on the date of the grant.

The options expire on September 26, 2034.

On July 9, 2024, Mr. Singh sold 11,751 shares of Issuer's common stock at an average of $1.593 per share. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person shall provide full information regarding the number of shares purchased at each separate price.

On July 8, 2024, Mr. Singh sold 10,670 shares of Issuer's common stock at an average price of $1.4704 per share. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person shall provide full information regarding the number of shares purchased at each separate price.

On July 5, 2024, Mr. Singh sold 7,095 shares of Issuer's common stock at an average price of $1.5799 per share. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person shall provide full information regarding the number of shares purchased at each separate price.

On July 3, 2024, Mr. Singh sold 2,757 shares of Issuer's common stock at an average of $1.6613 per share. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person shall provide full information regarding the number of shares purchased at each separate price.

On July 2, 2024, Mr. Singh sold 3,808 shares of Issuer's common stock at an average price of $1.666 per share. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person shall provide full information regarding the number of shares purchased at each separate price.

On July 1, 2024, Mr. Singh sold 13,919 shares of Issuer's common stock at an average price of $1.7317 per share. The sale price represents the weighted average sale price for multiple transactions reported. Upon request by the Commission, the Issuer or the Reporting Person shall provide full information regarding the number of shares purchased at each separate price.

The options vest as follows: 26,333 options were deemed immediately vested and, 26,333 shares vest after the first year, and 26,333 shares vest after they second year.

The shares were issued pursuant as a grant under the company's equity incentive plan based on the market price on the date of the grant.

The option expires on January 18, 2029.

The options vest as follows:11,500 options were deemed immediately vested and, 11,500 shares vest after the first year, and 11,500 shares vest after the second year.

The shares were issued pursuant as a grant under the company's equity incentive plan based on the market price on the date of the grant.

The option expires on January 18, 2029.